Anti-BCL3 aptamer SELEX Service(Cat#: CTApt-1867)

This is an aptamer development services to screening aptamers binds to the BCL3 with an affinity of 1nM~1μM.

Datasheet MSDS COA
Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target BCL3
Alternative Names BCL3 Transcription Coactivator; Chronic Lymphatic Leukemia Protein; B-Cell Lymphoma 3-Encoded Protein; B-Cell Leukemia/Lymphoma 3; B-Cell Lymphoma 3 Protein; B Cell CLL/Lymphoma 3; Proto-Oncogene BCL3; D19S37; BCL-3; BCL4; BCL3, Transcription Coactivator; BCL3
Gene ID 602
UniProt ID P20749
Target Overview This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry
×